Niruja Product Development And Healthcare Research Private Limited - Company Profile

It is a healthcare private limited company based in Bangalore, Karnataka, India, established in 2007.
2007 Bangalore, Karnataka, India Active
Last Updated:
About Niruja Product Development And Healthcare Research Private Limited

Niruja Product Development And Healthcare Research Private Limited, a active private limited company, was established on 13 December 2007 in Bangalore, Karnataka, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U73100KA2007PTC044658. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.80 Cr and a paid-up capital of ₹4.80 Cr.

Formerly known as Mims Hcg Oncology Private Limited. It upholds a compliant status. Its leadership includes Ramesh S Bilimagga (Director), Manish Mattoo (Additional Director). Past directors included Abdulla Cherayakkat, Anant Shrinivas Kittur, Ramesh S Bilimagga. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Hcg Tower, No.8. P.Kalinga Rao Road Sampangi Rama Nagar,, Bangalore, Karnataka, 560027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2007PTC044658

  • Registration Number

    044658

  • Incorporation Date

    13 December 2007

  • Authorized Capital

    ₹4.80 Cr

  • Paid-Up Capital

    ₹4.80 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.80 Cr
  • Paid Up Capital ₹ 4.80 Cr
  • Company Age 18 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth 17.12%
  • Total Assets **** 1.26%
Company report

Niruja Product Development And Healthcare Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Niruja Product Development And Healthcare Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Niruja Product Development And Healthcare Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramesh S Bilimagga Director 30 Mar 2015 Current
Manish Mattoo Additional Director 30 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Jan 2011 Past
Pramod Abcsdd Additional Director 29 Sep 2016 Past
Pramod Abcsdd Additional Director 22 Sep 2015 Past
Pramod Abcsdd Director 28 Sep 2017 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Niruja Product Development And Healthcare Research.

Niruja Product Development And Healthcare Research Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 17.12%.

Niruja Product Development And Healthcare Research revenue growth over time
Niruja Product Development And Healthcare Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
1.26%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
17.12%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Niruja Product Development And Healthcare Research?

In 2023, Niruja Product Development And Healthcare Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Niruja Product Development And Healthcare Research?

Unlock and access historical data on people associated with Niruja Product Development And Healthcare Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Niruja Product Development And Healthcare Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niruja Product Development And Healthcare Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Niruja Product Development And Healthcare Research
Recent Activity within the Organization
  • Annual General Meeting

    Niruja Product Development And Healthcare Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Manish Mattoo was appointed as a Additional Director was appointed as a Additional Director on 30 Jun 2025 & has been associated with this company since 7 months 26 days . was documented.

  • Balance Sheet

    Niruja Product Development And Healthcare Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    The activity Ramesh S Bilimagga was appointed as a Director was appointed as a Director on 30 Mar 2015 & has been associated with this company since 10 years 10 months . was completed.

  • Company Incorporation

    Progress on Niruja Product Development And Healthcare Research Private Limited was registered on 13 Dec 2007 with Roc Bangalore & aged 18 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Niruja Product Development And Healthcare Research Private Limited?

The CIN of Niruja Product Development And Healthcare Research Private Limited is U73100KA2007PTC044658.

Where is Niruja Product Development And Healthcare Research Private Limited headquartered?

Niruja Product Development And Healthcare Research Private Limited is headquartered at Hcg Tower, No.8. P.Kalinga Rao Road Sampangi Rama Nagar,, Bangalore, Karnataka, 560027.

When was Niruja Product Development And Healthcare Research Private Limited incorporated?

Niruja Product Development And Healthcare Research Private Limited was incorporated on 13 December 2007.

Who are the current directors of Niruja Product Development And Healthcare Research Private Limited?

The current directors of Niruja Product Development And Healthcare Research Private Limited are

What is the primary industry of Niruja Product Development And Healthcare Research Private Limited?

The primary industry of Niruja Product Development And Healthcare Research Private Limited is Hospital And Medical Care.

Is Niruja Product Development And Healthcare Research Private Limited a listed company?

Niruja Product Development And Healthcare Research Private Limited is unlisted.

What is the capital structure of Niruja Product Development And Healthcare Research Private Limited?

The authorized capital of Niruja Product Development And Healthcare Research Private Limited is ₹4.80 Cr, and the paid-up capital is ₹4.80 Cr.

What is the compliance status of Niruja Product Development And Healthcare Research Private Limited?

The compliance status of Niruja Product Development And Healthcare Research Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available